How big is the Plasma Protein Therapeutics Market?

The Plasma Protein Therapeutics Market size is expected to reach USD 30.49 billion in 2024 and grow at a CAGR of 5.5% to reach USD 39.85 billion by 2029. Read More

What is the current Plasma Protein Therapeutics Market size?

In 2024, the Plasma Protein Therapeutics Market size is expected to reach USD 30.49 billion. Read More

Who are the key players in Plasma Protein Therapeutics Market?

Octapharma USA Inc., Takeda Pharmaceutical Company Limited, Biotest UK, Grifols, S.A. and CSL Limited are the major companies operating in the Plasma Protein Therapeutics Market. Read More

Which is the fastest growing region in Plasma Protein Therapeutics Market?

Asia-Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029). Read More

Which region has the biggest share in Plasma Protein Therapeutics Market?

In 2024, the North America accounts for the largest market share in Plasma Protein Therapeutics Market. Read More

What years does this Plasma Protein Therapeutics Market cover, and what was the market size in 2023?

In 2023, the Plasma Protein Therapeutics Market size was estimated at USD 28.81 billion. The report covers the Plasma Protein Therapeutics Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Plasma Protein Therapeutics Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

Plasma Protein TherapeuticsCompanies

This report lists the top Plasma Protein Therapeutics companies based on the 2023 & 2024 market share reports. Mordor Intelligence expert advisors conducted extensive research and identified these brands to be the leaders in the Plasma Protein Therapeutics industry.